Revised EC GMP Guideline Urges Investigation of Quality Defects, Complaints

Manufacturers operating in Europe should report any product-quality defect to the drug application holders and individual EU regulatory bodies if the incident requires a recall or creates supply restrictions, according to a revised chapter of a European Commission guideline on good manufacturing practices.
Drug Industry Daily